Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFCD2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $179,918
Award facts
- Contract value 100% obligated
- $179,917.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $179,917.64 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was not set aside for any particular business category. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its significant IDC with the DLA to fulfill federal medical procurement requirements across the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies through competitive procurement processes. Cosentyx, a specialty biologic medication used for immunological and inflammatory conditions, is among the specialized pharmaceuticals the contractor regularly delivers to support military healthcare programs. The firm fixed-price delivery order structure and rapid completion timeline reflect the operational flexibility and supply chain efficiency that characterize AmerisourceBergen's role as a critical pharmaceutical vendor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FFCD2?
SPE2DB25FFCD2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FFCD2 worth?
The government has obligated $179,918 on SPE2DB25FFCD2.
Is contract SPE2DB25FFCD2 an order under another contract?
Yes. SPE2DB25FFCD2 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFCD2 competed?
The extent of competition for SPE2DB25FFCD2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award